首页> 外文OA文献 >Results from HARMONY: an open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis

【2h】

Results from HARMONY: an open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis

机译：和谐的结果：开放标签，多中心，2臂，第1B期，剂量发现研究评估Ruxolitinib和Buptlisib在肌肌纤维症患者中的口腔组合的安全性和功效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Simon T. Durrant; Arnon Nagler; Paola Guglielmelli; David Lavie; Philipp le Coutre; Heinz Gisslinger; Charles Chuah; Margherita Maffioli; Savita Bharathy; Tuochuan Dong; Monika Wroclawska; Joaquin Martinez Lopez;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Results from HARMONY: an open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis [J] . Simon T. Durrant, Arnon Nagler, Paola Guglielmelli, Haematologica . 2019,第12期

机译：HARMONY的结果：一项开放性，多中心，2臂，1b期的剂量寻找研究，评估ruxolitinib和buparlisib口服组合在骨髓纤维化患者中的安全性和有效性
2. The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis [J] . Mary Frances McMullin, Claire N. Harrison, Dietger Niederwieser, Experimental Hematology Oncology . 2015,第1期

机译：ruxolitinib促红细胞生成素促进剂在COMFORT-II骨髓纤维化患者中的使用：一项开放性的3期研究，评估ruxolitinib与最佳治疗骨髓纤维化的疗效和安全性
3. Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis [J] . Komatsu Norio, Kirito Keita, Shimoda Kazuya, International journal of hematology . 2017,第3期

机译：评估ruxolitinib在日本骨髓症患者中ruxolitinib在多中心的开放式研究中的安全性和有效性
4. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
5. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
6. Results from HARMONY: an open-label multicenter 2-arm phase 1b dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis [O] . Simon T. Durrant, Arnon Nagler, Paola Guglielmelli, 2019

机译：HARMONY的结果：一项开放性多中心2臂1b期的剂量寻找研究评估鲁索替尼和布帕西布口服组合在骨髓纤维化患者中的安全性和有效性
7. Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study [O] . Vikas Gupta, Denise Wolleschak, Hans Hasselbalch, 2020

机译：Sonidegib和Ruxolitinib在骨髓纤维化中的安全性和疗效：1B / 2剂量查找研究

Results from HARMONY: an open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis

著录项

引文网络

相似文献

相关主题

期刊订阅